Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide (Genvoya)
- Status:
- Red
- Decision Date:
- April 2023
Comments
RED:
Treatment of human
immunodeficiency virus-1 infection without any known mutations associated with
resistance to the integrase inhibitor class.Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again